Cambridge Enterprise Limited hosts the 4th Cambridge Biotechnology Cluster event celebrati...


28-09-2007

Has Europe’s biggest biotechnology cluster located in the Cambridge Technopole region grown, stagnated or changed shaped in the past 18 months? The 4th edition of the Cambridge Biotechnology Cluster Map, produced by Cambridge Enterprise Limited, University of Cambridge was unveiled this week.

An evening reception held at King’s College, Cambridge, was attended by a number of esteemed entrepreneurial biotech scientists from the University of Cambridge, as well as senior representatives from the big pharma companies and Cambridge’s newer biotechnology companies.

Andrew Lynn, Chief Executive of OrthoMimetics commented “the unparalleled scientific and medical expertise combined with strong strategic collaboration between established and emerging commercial enterprises has seen Cambridge develop into a world-leading centre for innovation-driven businesses in the life-sciences sector. It is an honour and a pleasure to be a part an event that celebrates this accomplishment." OrthoMimetics was spun-out of the University of Cambridge and the Massachusetts Institute of Technology in 2005.

Dr Iain Thomas, Head of Life Sciences, Cambridge Enterprise thanked the guests and said “It is so easy to take for granted the extraordinary nature of the biotech cluster in the Cambridge area. It has come about because of the commitment and hard works of many people and organisations, including the University of Cambridge. It is wonderful to be able to bring the local biotech community together at an event that celebrates past collective success and looks to future greater achievement."

The event was sponsored by Boult Wade Tennant, Carter Jonas, Deloitte, Genzyme, Greater Cambridge Partnership, Merck Sharp & Dohme, E-Center Massachusetts Institute of Technology, Taylor Vinters and Venner Shipley. Supporters of the event included Eastern Region Biotechnology Initiative, Biology in Business and the Cambridge Network.

The Cambridge Biotechnology Cluster 2007 Map can be obtained from Cambridge Enterprise Limited, email biotech@enterprise.cam.ac.uk

Cambridge Enterprise Limited, University of Cambridge

Cambridge Enterprise provides knowledge and technology commercialisation services to University staff and students. Services provided include intellectual property management, bespoke marketing, technology licences and consultancy contracts negotiation. Additionally, Cambridge Enterprise assists in company creation through start-up clinics, one-to-one mentoring, and access to investors, and experienced management and seed capital.

During 2005-06 there were 58 new patent applications filed, 152 invention disclosures were made, and a total of 61 new licences and other commercial agreements were signed. Income from patent and software licences exceeded £3.3m, and demand for academics' technical advice added a further £2.9 million of revenue. £5.3m was distributed to inventors and their departments and four new University spin-out companies were launched.

Further information on Cambridge Enterprise can be found at: www.enterprise.cam.ac.uk

*******

For further information please contact: Shirley Jamieson, Head of Marketing, Cambridge Enterprise Limited shirley.jamieson@enterprise.cam.ac.uk 01223 760339 .

 

Cambridge Enterprise exists to help University of Cambridge inventors, innovators and entrepreneurs make their ideas and concepts more commercially successful for the benefit of society, the UK economy, the inventors and the University.

Cambridge Enterprise, University of Cambridge